Xiang Xiao Selected Research

Xiang Xiao Research Topics

Disease

16	Neoplasms (Cancer) 09/2021 - 06/2009
9	Body Weight (Weight, Body) 01/2021 - 09/2010
8	Obesity 08/2022 - 03/2017
8	Inflammation (Inflammations) 01/2022 - 01/2012
4	Ischemic Stroke 04/2016 - 01/2012
4	Stroke (Strokes) 10/2015 - 01/2012
4	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 11/2013 - 02/2012
3	Ischemia 01/2021 - 01/2012
3	Hypertension (High Blood Pressure) 01/2020 - 01/2019
3	Vascular Diseases (Vascular Disease) 09/2017 - 01/2015
3	Behcet Syndrome (Behcet's Syndrome) 01/2016 - 08/2012
3	Infarction (Infarctions) 10/2015 - 01/2012
2	Glucose Intolerance 08/2022 - 12/2016
2	Osteoarthritis 06/2022 - 01/2022
2	Kashin-Beck Disease 06/2022 - 01/2022
2	Fibrosis (Cirrhosis) 06/2022 - 06/2016
2	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2018
2	Infections 01/2022 - 03/2021
2	Pneumonia (Pneumonitis) 07/2021 - 01/2018
2	Autism Spectrum Disorder 04/2020 - 01/2020
2	Cysts 10/2018 - 06/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2018
2	Overweight 01/2018 - 03/2013
2	Hypoxia (Hypoxemia) 01/2017 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2015
2	Shock 12/2016 - 04/2006
2	Seizures (Absence Seizure) 01/2009 - 01/2008
1	Dyslipidemias (Dyslipidemia) 06/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Multiple Myeloma 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Weight Gain 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Hemorrhage 11/2021
1	Acute Coronary Syndrome 11/2021

Drug/Important Bio-Agent (IBA)

9	LipidsIBA 08/2022 - 03/2017
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2013
6	erucylphosphocholineIBA 09/2017 - 01/2012
5	Indicators and Reagents (Reagents)IBA 06/2021 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2012
3	Therapeutic UsesIBA 01/2021 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2012
3	Triglycerides (Triacylglycerol)IBA 10/2019 - 12/2016
3	Oxygen (Dioxygen)IBA 09/2010 - 01/2008
2	Insulin (Novolin)FDA Link 08/2022 - 04/2018
2	Interleukin-7 (Interleukin 7)IBA 01/2022 - 02/2012
2	ORALIT (ORS)IBA 01/2022 - 01/2017
2	C-Reactive ProteinIBA 01/2022 - 01/2012
2	CytokinesIBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 12/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021 - 01/2016
2	GlucansIBA 11/2020 - 03/2017
2	spleen fibrinolytic proteinase (human) (SFP)IBA 04/2020 - 01/2020
2	AntigensIBA 01/2020 - 01/2020
2	CholesterolIBA 10/2019 - 12/2016
2	Air Pollutants (Pollutants, Air)IBA 01/2019 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 05/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 02/2012
2	LigandsIBA 01/2016 - 05/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2016 - 07/2012
2	angiotensin I (1-7)IBA 10/2015 - 03/2013
2	Angiotensin IIIBA 01/2014 - 03/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2012 - 05/2012
1	PowdersIBA 08/2022
1	SeleniumIBA 06/2022
1	Chemotactic FactorsIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA 01/2022
1	alpha-SynucleinIBA 01/2022
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	InterferonsIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 11/2021
1	Hematoxylin (Haematoxylon)IBA 11/2021
1	AnticoagulantsIBA 11/2021
1	bivalirudin (Angiomax)FDA Link 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2021

Therapy/Procedure

8	Therapeutics 01/2021 - 03/2013
3	Transplantation 09/2017 - 10/2015
2	Percutaneous Coronary Intervention 11/2021 - 09/2021
2	Drug Therapy (Chemotherapy) 07/2019 - 01/2018
1	Stents 11/2021